Page last updated: 2024-09-03

bw 373u86 and Ache

bw 373u86 has been researched along with Ache in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ajello, CW; Barker, WM; Belanger, S; Brogdon, BL; Cassel, JA; Christ, DD; Chu, GH; DeHaven, RN; DeHaven-Hudkins, DL; Derelanko, MJ; Dolle, RE; Feschenko, MS; Graczyk, TM; Gu, M; Koblish, M; Kutz, S; Le Bourdonnec, B; Leister, LK; Little, PJ; Smith, SA; Tuthill, PA; Wiant, DD; Windh, RT1
Butelman, ER; Chang, KJ; Gatch, MB; Negus, SS; Woods, JH1

Other Studies

2 other study(ies) available for bw 373u86 and Ache

ArticleYear
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859).
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Administration, Oral; Analgesics; Animals; Benzamides; Benzopyrans; Biological Availability; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Ether-A-Go-Go Potassium Channels; Humans; Maximum Tolerated Dose; Mice; Molecular Structure; Motor Activity; Pain; Pain Measurement; Rats; Receptors, Opioid, delta; Toxicity Tests

2008
BW373U86, a delta-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys.
    European journal of pharmacology, 1995, Apr-24, Volume: 277, Issue:2-3

    Topics: Animals; Benzamides; Bradykinin; Dinoprostone; Dose-Response Relationship, Drug; Female; Hyperalgesia; Injections, Subcutaneous; Macaca mulatta; Male; Pain; Piperazines; Receptors, Opioid, delta; Skin

1995